agilon health (NYSE:AGL – Free Report) had its target price reduced by Deutsche Bank Aktiengesellschaft from $5.00 to $4.00 in a report published on Friday morning, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock.
Several other analysts have also recently commented on AGL. Baird R W upgraded agilon health to a hold rating in a report on Thursday, May 30th. Citigroup began coverage on agilon health in a research note on Monday, April 22nd. They issued a neutral rating and a $6.00 price target on the stock. Robert W. Baird began coverage on agilon health in a research note on Thursday, May 30th. They issued a neutral rating and a $6.00 price target on the stock. Evercore ISI boosted their price target on agilon health from $5.50 to $7.00 and gave the company an in-line rating in a research note on Tuesday, July 9th. Finally, Truist Financial upped their target price on agilon health from $6.40 to $6.50 and gave the stock a hold rating in a research report on Friday, May 24th. One analyst has rated the stock with a sell rating, fourteen have given a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of Hold and an average target price of $8.57.
View Our Latest Stock Report on agilon health
agilon health Trading Down 1.4 %
agilon health (NYSE:AGL – Get Free Report) last announced its earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, meeting the consensus estimate of ($0.07). agilon health had a negative return on equity of 26.15% and a negative net margin of 5.67%. The business had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the prior year, the business posted ($0.04) earnings per share. The firm’s revenue was up 38.7% on a year-over-year basis. On average, analysts predict that agilon health will post -0.34 earnings per share for the current fiscal year.
Institutional Investors Weigh In On agilon health
Several institutional investors have recently bought and sold shares of AGL. Capital International Investors grew its stake in agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after purchasing an additional 9,263,296 shares during the period. Capital World Investors grew its stake in agilon health by 7.4% in the 4th quarter. Capital World Investors now owns 55,218,496 shares of the company’s stock valued at $692,992,000 after purchasing an additional 3,813,214 shares during the period. Price T Rowe Associates Inc. MD grew its stake in agilon health by 46.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock valued at $127,256,000 after purchasing an additional 3,195,087 shares during the period. Norges Bank bought a new position in agilon health in the 4th quarter valued at $27,902,000. Finally, Wellington Management Group LLP grew its stake in shares of agilon health by 2.9% during the 4th quarter. Wellington Management Group LLP now owns 42,510,030 shares of the company’s stock worth $533,501,000 after acquiring an additional 1,191,253 shares during the period.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
- Five stocks we like better than agilon health
- Earnings Per Share Calculator: How to Calculate EPS
- Why Wall Street Analysts Raised Price Targets for Suncor Stock
- The Significance of Brokerage Rankings in Stock Selection
- Is Super Micro Computer a Buy After Shares Sink 20% on Earnings?
- Conference Calls and Individual Investors
- MarketBeat Week in Review – 8/5 – 8/9
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.